Hong-Xing Pan

Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology

Nanjing

China

SCHOLARLY PAPERS

4

DOWNLOADS

1,122

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Immunogenicity and Safety of BNT162b2 mRNA Vaccine in Chinese Adults: A Randomized Clinical Trial

Number of pages: 35 Posted: 19 May 2022
Fosun Pharma (USA), Southeast University - School of Public Health, Taizhou People’s Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Taizhou Vaccine Clinical Research Center, Taizhou People’s Hospital, Fosun Pharma (China), Fosun Pharma (China), Taizhou Vaccine Clinical Research Center, Taizhou People’s Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, Lianshui Center for Disease Control and Prevention, Fosun Pharma (China), Fosun Pharma (China), Fosun Pharma (China), BioNTech (Germany), BioNTech (Germany), BioNTech (USA), Fosun Pharma (China), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany), BioNTech (USA), BioNTech (USA), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany) and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 537 (78,952)

Abstract:

Loading...

BNT162b2 mRNA vaccine, COVID-19, intramuscular injection, messenger RNA, neutralizing antibodies, SARS-CoV-2, vaccination

2.

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Number of pages: 26 Posted: 04 Jan 2022
Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 447 (98,548)

Abstract:

Loading...

Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial

3.

Safety and Immunogenicity of Heterologous Boosting With a Protein-Subunit-Based COVID-19 Vaccine (ZF2001) in Healthy Adults Previously Received One Dose of Convidecia: A Randomised, Observer-Blinded, Placebo-Controlled Trial

Number of pages: 36 Posted: 10 Jan 2022
Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Guanyun County Center for Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Nanjing Vazyme Biotech Co., Ltd., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Guanyun County Center for Disease Control and Prevention, Southeast University, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Vazyme Biotech Co., Ltd., Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Nanjing Medical University, Southeast University - School of Public Health and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 79 (455,238)

Abstract:

Loading...

SARS-CoV-2, heterologous immunisation, recombinant adenovirus type-5-vectored COVID-19 vaccine, protein-subunit-based COVID-19 vaccine, clinical trial

4.

Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial

Number of pages: 24 Posted: 30 Dec 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Medical University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Southeast University - School of Public Health
Downloads 59 (530,925)

Abstract:

Loading...